Location · Texas
Clinical trials recruiting in Texas
1575 recruiting studies have at least one site in Texas; 474 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Texas.
1,575 recruiting studiesSource: ClinicalTrials.gov, refreshed October 27, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2/Phase 3
A Study of Buntanetap in Participants With PD
Annovis Bio Inc.
- Location
- Round Rock, TX + 26 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Dompé Farmaceutici S.p.A
- Location
- Houston, TX + 7 other US sites
- Eligibility basics
- Ages 10–65
- RecruitingPhase 2
A Study in Adults With Geographic Atrophy
Sitala Bio LTD
- Location
- Burleson, TX + 1 other US site
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
AstraZeneca
- Location
- El Paso, TX + 3 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
ReGelTec, Inc.
- Location
- Tyler, TX + 13 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Novo Nordisk A/S
- Location
- Houston, TX + 8 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Takeda
- Location
- Houston, TX + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Optinose US Inc.
- Location
- Austin, TX + 18 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 4
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Neurocrine Biosciences
- Location
- Austin, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
AstraZeneca
- Location
- Allen, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Vertex Pharmaceuticals Incorporated
- Location
- El Paso, TX + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Dallas, TX + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 1/Phase 2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
AbbVie
- Location
- Dallas, TX + 10 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 2/Phase 3
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
Takeda
- Location
- Austin, TX + 16 other US sites
- Eligibility basics
- Ages 18–71
- Recruiting
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Pulmonx Corporation
- Location
- Dallas, TX + 17 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Houston, TX + 42 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
- Location
- El Paso, TX + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Austin, TX + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Transcend Therapeutics
- Location
- Austin, TX + 36 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
Providence Medical Technology, Inc.
- Location
- Frisco, TX + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
Neurocrine Switzerland GmbH
- Location
- Dallas, TX + 10 other US sites
- Eligibility basics
- Ages 4 mo–3
- RecruitingPhase 3
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ascletis Pharma (China) Co., Limited
- Location
- Austin, TX + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ascletis Pharma (China) Co., Limited
- Location
- Austin, TX + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- El Paso, TX + 3 other US sites
- Eligibility basics
- Ages 16+